Journal
INTERNAL MEDICINE JOURNAL
Volume 47, Issue 6, Pages 701-704Publisher
WILEY
DOI: 10.1111/imj.13442
Keywords
diabetic ketoacidosis; diabetes mellitus; type 2; sodium-glucose transporter 2; hypoglycaemic agents; humans
Categories
Ask authors/readers for more resources
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are an increasingly prescribed class of medication for type 2 diabetes mellitus. Euglycaemic diabetic ketoacidosis (euDKA) has been reported in association with SGLT2i use. Clinicians need to understand how to recognise and treat this complication. We describe three cases of euDKA in patients treated with SGLT2i.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
